Marc Andersen

787 total citations · 1 hit paper
9 papers, 663 citations indexed

About

Marc Andersen is a scholar working on Endocrinology, Diabetes and Metabolism, Health and Immunology. According to data from OpenAlex, Marc Andersen has authored 9 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Health and 2 papers in Immunology. Recurrent topics in Marc Andersen's work include Diabetes Treatment and Management (5 papers), Diabetes Management and Research (5 papers) and Immune responses and vaccinations (2 papers). Marc Andersen is often cited by papers focused on Diabetes Treatment and Management (5 papers), Diabetes Management and Research (5 papers) and Immune responses and vaccinations (2 papers). Marc Andersen collaborates with scholars based in Denmark, Japan and Czechia. Marc Andersen's co-authors include Brian Larsen Thorsted, Michael Lyng Wolden, Melanie J. Davies, Kamlesh Khunti, Peter Aaby, Kim Knudsen, Hiroshi Maegawa, Annabel Desgrées du Loû, Yasushi Ishigaki and J Langer and has published in prestigious journals such as Blood, PLoS ONE and Diabetes Care.

In The Last Decade

Marc Andersen

8 papers receiving 644 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Inertia in People With Type 2 Diabetes

2013 482 citations Kamlesh Khunti, Michael Lyng Wolden et al. Diabetes Care profile →

Peers

Marc Andersen

EDM

MB

SURGE

EPIDE

GENET

Bogdan Vlacho Spain

Kate Van Brunt United States

Chris Van Schravendijk Belgium

Domenico Mannino Italy

Mads Faurby Denmark

Nelson Rassi Brazil

Sergio Di Molfetta Italy

F. Ismail-Beigi United States

Barbara Tartaglino Italy

Sherry Martin United States

Bogdan Vlacho Spain

Marc Andersen

285 ×0.5

EDM

59 ×0.4

MB

64 ×0.7

SURGE

71 ×1.0

EPIDE

45 ×0.7

GENET

Citations per year, relative to Marc Andersen Marc Andersen (= 1×) peers Bogdan Vlacho

Countries citing papers authored by Marc Andersen

Since Specialization

Citations

This map shows the geographic impact of Marc Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Andersen more than expected).

Fields of papers citing papers by Marc Andersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Andersen. The network helps show where Marc Andersen may publish in the future.

Co-authorship network of co-authors of Marc Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Andersen. A scholar is included among the top collaborators of Marc Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Andersen. Marc Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Maegawa, Hiroshi, et al.. (2020). Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53). Journal of Diabetes Investigation. 12(3). 374–381. 15 indexed citations

2.

Satoh, Jo, Marc Andersen, Brian Bekker Hansen, et al.. (2018). Clinical inertia in basal insulin-treated patients with type 2 diabetes – Results from a retrospective database study in Japan (JDDM 43). PLoS ONE. 13(9). e0198160–e0198160. 15 indexed citations

3.

Sreenan, Séamus, Marc Andersen, Brian Larsen Thorsted, Michael Lyng Wolden, & Marc Evans. (2014). Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes. Diabetes Therapy. 5(2). 447–458. 14 indexed citations

4.

Khunti, Kamlesh, Michael Lyng Wolden, Brian Larsen Thorsted, Marc Andersen, & Melanie J. Davies. (2014). Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More Than 80,000 People. Diabetes Care. 80 indexed citations

5.

Khunti, Kamlesh, Michael Lyng Wolden, Brian Larsen Thorsted, Marc Andersen, & Melanie J. Davies. (2013). Clinical Inertia in People With Type 2 Diabetes. Diabetes Care. 36(11). 3411–3417. 482 indexed citations breakdown →

6.

Wierda, William G., Thomas J. Kipps, Jan Dürig, et al.. (2009). Ofatumumab Combined with Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Results From a Randomized, Multicenter, International, Two-Dose, Parallel Group, Phase II Trial.. Blood. 114(22). 207–207. 21 indexed citations

7.

Aaby, Peter, Gilles Pison, Annabel Desgrées du Loû, & Marc Andersen. (1995). Lower Mortality for Female-Female Twins than Male-Male and Male-Female Twins in Rural Senegal. Epidemiology. 6(4). 419–422. 11 indexed citations

8.

Aaby, Peter, et al.. (1994). [Measles vaccination and age].. PubMed. 156(40). 5857–61. 1 indexed citations

9.

Aaby, Peter, Marc Andersen, & Kim Knudsen. (1993). Excess Mortality after Early Exposure to Measles. International Journal of Epidemiology. 22(1). 156–162. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact